Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.38 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL882530 | 0.86 | TMPRSS2 (0.41) | TMPRSS2PIK3CD | |
| SCHEMBL24789693 | 0.84 | POLRMT (0.38) | POLRMTTMPRSS2PIK3CD | |
| SCHEMBL18697904 | 0.84 | TMPRSS2 (0.43) | POLRMTTMPRSS2 | |
| SCHEMBL24074599 | 0.84 | POLRMT (0.49) | POLRMTTMPRSS2 | |
| SCHEMBL24791772 | 0.83 | POLRMT (0.37) | POLRMTTMPRSS2PIK3CD | |
| SCHEMBL20078643 | 0.83 | POLRMT (0.37) | POLRMTTMPRSS2 | |
| SCHEMBL17719237 | 0.83 | TMPRSS2 (0.50) | POLRMTTMPRSS2 | |
| SCHEMBL10082720 | 0.82 | BACE1 (0.34) | TMPRSS2PIK3CD | |
| SCHEMBL24606306 | 0.82 | TMPRSS2 (0.41) | POLRMTTMPRSS2PIK3CD | |
| SCHEMBL20078677 | 0.81 | TMPRSS2 (0.40) | POLRMTTMPRSS2PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130034521-A1 | 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2013-02-07 | — | — | US | disclosed |
| US-8008264-B2 | 1′-substituted carba-nucleoside analogs for antiviral treatment | GILEAD SCIENCES, INC. (US) | 2011-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130034521-A1 | 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | PNP, MTAP, SLC29A1 | POLRMT 263/4885TMPRSS2 1945/4885PIK3CD 334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.